Vectors Research Management, LLC Cyma Bay Therapeutics, Inc. Transaction History

Vectors Research Management, LLC

  • $330 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022
BUY
$1.72 - $3.39 $10,320 - $20,340
6,000 New
6,000 $18,000
Q1 2022

May 16, 2022
SELL
$2.77 - $3.64 $16,620 - $21,840
-6,000 Closed
0 $0
Q4 2021

Feb 15, 2022
BUY
$3.23 - $4.6 $3,230 - $4,600
1,000 Added 20.0%
6,000 $20,000
Q2 2021

Aug 09, 2021
BUY
$3.94 - $4.92 $19,700 - $24,600
5,000 New
5,000 $21,000

Others Institutions Holding CBAY

# of Institutions
6
Shares Held
1.82M
Call Options Held
0
Put Options Held
0
View Full List

About CymaBay Therapeutics, Inc.

CBAY Quotes by TradingView
  • Ticker CBAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 84,677,904
  • Description
  • CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta that is in phase III clinical study for the treatments of pri...
More about CBAY
Track This Portfolio

Track Vectors Research Management, LLC Portfolio

Follow Vectors Research Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vectors Research Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vectors Research Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email